Valuation: Hugel, Inc.

Market Cap 1,864B 1.39B 1.25B 1.17B 1.06B 1.98B 132B 1.99B 13.98B 5.46B 68.58B 5.21B 5.1B 221B P/E 2026 *
13.7x
P/E 2027 * 10.4x
Enterprise Value 1.31B 975K 877K 818K 741K 1.39M 92.78M 1.4M 9.82M 3.83M 48.15M 3.66M 3.58M 155M EV / Sales 2026 *
2.57x
EV / Sales 2027 * 1.83x
Free-Float
45.22%
Yield 2026 *
-
Yield 2027 * -
1 day+1.53%
1 week-6.05%
Current month-4.01%
1 month-25.65%
3 months-24.01%
6 months-31.82%
Current year-25.16%
1 week 164,100
Extreme 164100
182,400
1 month 164,100
Extreme 164100
234,500
Current year 164,100
Extreme 164100
308,500
1 year 164,100
Extreme 164100
308,500
3 years 131,600
Extreme 131600
392,000
5 years 99,700
Extreme 99700
392,000
10 years 75,865.91
Extreme 75865.908
392,000
Manager TitleAgeSince
Director of Finance/CFO 61 -
Chief Tech/Sci/R&D Officer 54 -
Chief Executive Officer 49 -
Director TitleAgeSince
Director/Board Member 54 2022-04-28
Director/Board Member 56 2022-04-28
Director/Board Member 51 2022-04-28
Date Insider Type Main position Quantity % Market Cap. Importance
5/20/25 Exercice 1,200 0.0095%
5/20/25 Sell 1,200 0.0095%
5/19/25 Exercice

Chairman

31,510 0.2500%
Change 5-day change 1-year change 3-year change Capi.($)
+1.53%-6.05%-35.15%+20.29% 1.37B
+3.62%+1.68%+48.80%+98.41% 1,040B
+2.13%-1.76%+33.04%+61.88% 599B
+3.32%+4.47%+23.72%+91.59% 485B
+3.80%+3.21%+73.99%+41.69% 350B
+3.09%+3.03%+29.59%+45.42% 345B
+2.82%+2.20%+17.90%+40.15% 272B
+3.40%+0.99%-3.44%+12.08% 244B
+3.21%+3.15%+45.01%+49.99% 223B
+3.80%+4.56%+29.59%+97.73% 183B
Average +2.87%+1.11%+26.31%+55.92% 374.42B
Weighted average by Cap. +2.66%+1.53%+36.76%+68.67%

Financials

2026 *2027 *
Net sales 509B 379M 341M 318M 288M 541M 36.09B 545M 3.82B 1.49B 18.73B 1.42B 1.39B 60.25B 645B 481M 432M 403M 366M 686M 45.75B 691M 4.84B 1.89B 23.74B 1.8B 1.77B 76.37B
Net income 153B 114M 102M 95.43M 86.49M 162M 10.82B 163M 1.15B 447M 5.62B 427M 418M 18.07B 202B 150M 135M 126M 114M 215M 14.3B 216M 1.51B 591M 7.42B 564M 552M 23.87B
Net Debt -555B -414M -372M -347M -314M -590M -39.36B -594M -4.16B -1.63B -20.43B -1.55B -1.52B -65.7B -681B -508M -456M -426M -386M -725M -48.31B -729M -5.11B -2B -25.07B -1.91B -1.86B -80.64B
Projected Income Statement - Annual - Hugel, Inc.
Logo Hugel, Inc.
Hugel Inc is a Korea-based company mainly engaged in the manufacture and sale of biopharmaceutical products. The Company is mainly engaged in the research, development, manufacturing, and sales of biopharmaceuticals utilizing type A botulinum toxin derived from the microorganism clostridium botulinum, as well as hyaluronic acid–based tissue‑restoration biomaterial filler products. In addition, the Company sells botulinum toxin products, hyaluronic acid fillers, cosmetics, skin boosters, and lifting threads. The Company distributes its products in domestic and overseas markets.
Employees
620
Date Price Change Volume
26-10-14 ₩172,500.00 +1.53% 46,666
26-10-13 ₩169,900.00 -5.61% 68,154
26-10-12 ₩180,000.00 -1.53% 64,190
26-10-08 ₩182,800.00 -0.44% 54,306
26-10-07 ₩183,600.00 +1.16% 32,479
Trader
Investor
Global
Quality
ESG MSCI
B
MarketScreener Ratings - Hugel, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
172,500.00KRW
Average target price
318,588.24KRW
Spread / Average Target
+84.69%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Hugel, Inc.
  1. Stock Market
  2. Stocks
  3. A145020 Stock